Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Agents for urinary incontinence and IBS in development at Pharmacia & Upjohn

April 17, 1998

New agents for BPH emerge from Synaptic/Merck & Co. collaboration

April 9, 1998

Expanded indication approved for Proscar

April 8, 1998

YM-905 shows promise as safe and effective treatment for overactive detrusor

April 6, 1998

RS-100975, a prostate-selective alpha-blocker in vitro

April 6, 1998

The alpha1L-adrenoceptor: a new target for BPH therapy

April 6, 1998

American Home Products synthesizes and evaluates new smooth muscle relaxants

April 6, 1998

Takeda claims bicyclic compounds for micturition disorders

April 6, 1998

Dual-action agent for BPH developed at Zeria

April 3, 1998

N-Alkylated saccharins from Merck & Co. with potential in BPH therapy

April 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...